Related Experiment Video

Updated: Aug 6, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

cdk6 can shorten G(1) phase dependent upon the N-terminal INK4 interaction domain

M J Grossel1, G L Baker, P W Hinds

  • 1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.

The Journal of Biological Chemistry
|October 9, 1999
PubMed

Insights

Cyclin-dependent kinase 6 (cdk6) overexpression accelerates cell cycle progression, promoting tumor growth. Its interaction with INK4 proteins is crucial for this oncogenic function.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Deregulated cyclin-dependent kinase 4 (cdk4) or cdk6 activity drives cellular proliferation and tumorigenesis.
  • The precise role of cdk6 in tumorigenesis is less understood compared to cdk4.
  • Tumor types exhibit preferential activation of either cdk4 or cdk6, indicating cell-type-specific oncogenic potential.

Purpose of the Study:

  • To investigate the proliferative requirements of aberrant cdk6 expression.
  • To elucidate the role of cdk6 in cell cycle progression and tumorigenesis.

Main Methods:

  • Overexpression of cdk6 in U2OS cells.
  • Analysis of cell cycle progression through G(1) phase.
  • Assessment of kinase activity and protein interactions (p27, INK4 proteins).
  • Site-directed mutagenesis to disrupt INK4 interaction (cdk6R31C).

Main Results:

  • cdk6 overexpression accelerated G(1) phase progression in a kinase-dependent manner.
  • This acceleration did not correlate with p27 binding.
  • A mutation (cdk6R31C) preventing INK4 interaction abolished the proliferative effect and increased cytoplasmic localization.
  • The cdk6R31C mutant retained in vitro retinoblastoma protein phosphorylation ability.

Conclusions:

  • The INK4 interaction domain of cdk6 is essential for generating functional, nuclear cdk6 complexes.
  • Elevated cdk6 kinase activity is critical for accelerating G(1) phase progression.
  • These findings highlight the importance of cdk6's interaction with INK4 proteins in its oncogenic function.

More Related Videos

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...